These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 10777696

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Osteoclastogenesis is decreased by cysteine proteinase inhibitors.
    Brage M, Lie A, Ransjö M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH.
    Bone; 2004 Mar; 34(3):412-24. PubMed ID: 15003789
    [Abstract] [Full Text] [Related]

  • 23. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 24. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M, Amano S.
    J Bone Miner Metab; 2004 Jun; 22(5):415-29. PubMed ID: 15316862
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H, Nakade O, Takada Y, Kaku T, Lau KH.
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [Abstract] [Full Text] [Related]

  • 27. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
    Xing L, Carlson L, Story B, Tai Z, Keng P, Siebenlist U, Boyce BF.
    J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
    [Abstract] [Full Text] [Related]

  • 28. High extracellular Ca2+ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors.
    Shin MM, Kim YH, Kim SN, Kim GS, Baek JH.
    Exp Mol Med; 2003 Jun 30; 35(3):167-74. PubMed ID: 12858015
    [Abstract] [Full Text] [Related]

  • 29. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P, Persson E, Conaway HH, Lerner UH.
    J Immunol; 2002 Sep 15; 169(6):3353-62. PubMed ID: 12218157
    [Abstract] [Full Text] [Related]

  • 30. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T.
    Endocrinology; 2000 Dec 15; 141(12):4711-9. PubMed ID: 11108286
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P, Lundgren I, Mukohyama H, Lehenkari PP, Horton MA, Lerner UH.
    Endocrinology; 2001 Jan 15; 142(1):339-47. PubMed ID: 11145597
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture.
    Takahashi E, Mukohyama H, Aoki K, Duarte WR, Lerner UH, Ohya K, Omura K, Kasugai S.
    J Med Dent Sci; 2002 Dec 15; 49(4):109-20. PubMed ID: 12641381
    [Abstract] [Full Text] [Related]

  • 36. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
    Evans CE, Mylchreest S, Andrew JG.
    BMC Musculoskelet Disord; 2006 Mar 06; 7():21. PubMed ID: 16519799
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.
    J Biol Chem; 2006 Feb 03; 281(5):2414-29. PubMed ID: 16251181
    [Abstract] [Full Text] [Related]

  • 40. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.